Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery.

about

Cataract surgery and its complications in diabetic patients.

P2860

Q38261111-EC545E5D-96DA-4C00-A87F-279FFCD13541

P2860

Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery.

Item

http://www.wikidata.org/entity/Q38068151

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Adjuvant treatment modalities ...... s undergoing cataract surgery.

@en

type

Item

label

Adjuvant treatment modalities ...... s undergoing cataract surgery.

@en

prefLabel

Adjuvant treatment modalities ...... s undergoing cataract surgery.

@en

P1476

Adjuvant treatment modalities ...... s undergoing cataract surgery.

@en

P2093

Cem Yıldırım

http://www.w3.org/2001/XMLSchema#string

Ebru Nevin Cetin

http://www.w3.org/2001/XMLSchema#string

P2860

The combination of intravitreal triamcinolone and phacoemulsification surgery in patients with diabeticfoveal oedema and cataract.

The natural history of macular edema after cataract surgery in diabetes.

Results after lens extraction in patients with diabetic retinopathy: early treatment diabetic retinopathy study report number 25.

Cataract surgery and diabetes.

Three-year follow-up of a randomized trial comparing focal/grid photocoagulation and intravitreal triamcinolone for diabetic macular edema.

Phacoemulsification with intravitreal bevacizumab injection in diabetic patients with macular edema and cataract.

Expanded 2-year follow-up of ranibizumab plus prompt or deferred laser or triamcinolone plus prompt laser for diabetic macular edema.

The RESTORE study: ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema.

Evaluation of changes of macular thickness in diabetic retinopathy after cataract surgery.

Intravitreal injection of ranibizumab during cataract surgery in patients with diabetic macular edema.

P2888

s10792-012-9695-1

P304

605-610

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1007/S10792-012-9695-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-12-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1000092951

http://www.w3.org/2001/XMLSchema#string

P698

23248073

http://www.w3.org/2001/XMLSchema#string

Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery.

about

P2860

P2860

Adjuvant treatment modalities to control macular edema in diabetic patients undergoing cataract surgery.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P6179

P698